BEAM
BEAM
NASDAQ · Biotechnology

Beam Therapeutics Inc

$24.63
-0.54 (-2.15%)
As of Mar 22, 10:00 PM ET ·
Analyst Consensus
Strong Buy
25
Analysts
High
Coverage
Buy 22 88%
Hold 3 12%
Sell 0 0%
Price Target
Analyst Price Target +152.0% upside
Low Target $37.88
Average Target $62.07
High Target $80.69
Current Price $24.63
Current
$24.63
Target
$62.07
$37.88 $62.07 avg $80.69
Scenario Analysis
Bear Case
$37.88
53.8%
Low target
Base Case
$62.07
+152.0%
Avg target
Bull Case
$80.69
+227.6%
High target
Risk/Reward
4.2x
Highly favorable
Price in Context
52-Week High
$36.44
-32.4% from high
52-Week Low
$13.53
+82.1% from low
50-Day SMA
$28.48
-13.5% vs SMA
200-Day SMA
$22.69
+8.6% vs SMA
RSI (14)
44.0
Neutral
Target vs 52W High
$62.07
+70.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%